During the COVID-19 pandemic, we all learned that keeping ourselves and our families healthy is our highest priority. On/Go™ is here to help. Whether you or someone in your family is feeling ill, has potentially been exposed or needs to demonstrate a negative test result, On/Go is the anytime, anywhere rapid antigen test to have on hand.
By connecting testing with real-time data to keep track of your family and their current status, you'll know you are ready to embark together on the next family vacation, take your child to their sporting events or just be confident when you are visiting your loved ones.
Even for those who are fully vaccinated, continued diligence is critical, including the use of rapid antigen testing. As variant strains emerge, On/Go and On/Go One COVID-19 Self-Test are a great way to remain confident in your health status when:
At On/Go we want to empower you to keep your employees safe, show them care and stay open for business. We believe that targeted timely communication, adherence to valid, repeated testing and real-time data provide the best holistic solution for employers and those in their care.
The On/Go and On/Go One tests have not been FDA cleared or approved but have been authorized by FDA under an Emergency Use Authorization (EUA). These products have been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens; the tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
The On/Go COVID-19 Antigen Self Test and the On/Go One COVID-19 Antigen Home Tests are lateral flow chromatographic immunoassays intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nasal swab specimens directly from individuals within 7 days of symptom onset or without symptoms or other epidemiological reasons to suspect COVID-19
